Cargando…

The effects of qishen granules for patients with chronic heart failure: A multicenter randomized double-blind placebo-controlled trial

Background: Despite advancements in chronic heart failure (CHF) treatment, the effect often remains unsatisfactory and unstable. More effective therapies are needed. Qishen granules (QSG) are a novel Chinese botanical drug effective in treating CHF in animal models, but clinical evidence remains ina...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Kangjia, Liu, Junjie, Tan, Nannan, Huang, Xinyi, Wang, Juan, Zhao, Huihui, Wang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822771/ https://www.ncbi.nlm.nih.gov/pubmed/36618925 http://dx.doi.org/10.3389/fphar.2022.1017734

Ejemplares similares

Efficacy and safety of Qishen granules for chronic heart failure: A protocol for systematic review and meta-analysis
por: Liu, Junjie, et al.
Publicado: (2020)

A Network Pharmacology Approach to Explore the Mechanisms of Qishen Granules in Heart Failure
por: Liu, Junjie, et al.
Publicado: (2019)

Antiapoptosis and Antifibrosis Effects of Qishen Granules on Heart Failure Rats via Hippo Pathway
por: Zhang, Jian, et al.
Publicado: (2019)

Corrigendum to “Antiapoptosis and Antifibrosis Effects of Qishen Granules on Heart Failure Rats via Hippo Pathway”
por: Zhang, Jian, et al.
Publicado: (2020)

Qishen Granule Improved Cardiac Remodeling via Balancing M1 and M2 Macrophages
por: Lu, Wenji, et al.
Publicado: (2019)

Safety and efficacy of Qishen granules in patients with chronic heart failure: study protocol for a randomized controlled trial
por: Wang, Jinping, et al.
Publicado: (2017)

Qishen granules regulate intestinal microecology to improve cardiac function in rats with heart failure
por: Gao, Kuo, et al.
Publicado: (2023)

Efficacy of Xinbao pill on chronic heart failure: Study protocol of a multicenter, randomized, double-blind, placebo-controlled trial
por: Wang, Yuanping, et al.
Publicado: (2022)

Qishen granules exerts cardioprotective effects on rats with heart failure via regulating fatty acid and glucose metabolism
por: Gao, Kuo, et al.
Publicado: (2020)

Decomposing the Mechanism of Qishen Granules in the Treatment of Heart Failure by a Quantitative Pathway Analysis Method
por: Ren, Weiquan, et al.
Publicado: (2018)

Clinical assessment of complementary treatment with Qishen Yiqi dripping pills on ischemic heart failure: study protocol for a randomized, double-blind, multicenter, placebo-controlled trial (CACT-IHF)
por: Hou, Ya Zhu, et al.
Publicado: (2013)

The Protective Effect of Qishen Granule on Heart Failure after Myocardial Infarction through Regulation of Calcium Homeostasis
por: Yang, Xiaomin, et al.
Publicado: (2020)

Qishen Granule (QSG) Inhibits Monocytes Released From the Spleen and Protect Myocardial Function via the TLR4-MyD88-NF-κB p65 Pathway in Heart Failure Mice
por: Li, Yanqin, et al.
Publicado: (2022)

Efficacy and Safety of Qishen Yiqi Dripping Pill for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis
por: Wang, Mengxi, et al.
Publicado: (2021)

Sijunzi decoction granules in the prevention and treatment of recurrence of colorectal adenoma: Study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
por: Ni, Wenjing, et al.
Publicado: (2023)

RNA-Seq Profiling to Investigate the Mechanism of Qishen Granules on Regulating Mitochondrial Energy Metabolism of Heart Failure in Rats
por: He, Hao, et al.
Publicado: (2021)

Protective Role of Enalapril in Anthracycline-Induced Cardiotoxicity: A Systematic Review
por: Zhang, Yili, et al.
Publicado: (2020)

Pingchan Granule for Motor Symptoms and Non-Motor Symptoms of Parkinson’s Disease: A Randomized, Double-Blind, Placebo-Controlled Study
por: Gu, Si-Chun, et al.
Publicado: (2022)

Effectiveness and safety of Qingfei Dayuan granules for treating influenza and upper respiratory tract infections manifested by the pulmonary heat-toxin syndrome: A multicenter, randomized, double-blind, placebo-controlled trial
por: Li, Weinan, et al.
Publicado: (2023)

A chinese medicine formula (kunbixiao granule) for female rheumatoid arthritis: Study protocol for a double-blind, randomized, placebo-controlled trial
por: Wan, Yingying, et al.
Publicado: (2022)

Qishen Granule Protects against Doxorubicin-Induced Cardiotoxicity by Coordinating MDM2-p53-Mediated Mitophagy and Mitochondrial Biogenesis
por: Li, Weili, et al.
Publicado: (2022)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Loki zupa in Patients With Chronic Asthma
por: Lv, Yubao, et al.
Publicado: (2018)

Corrigendum: A Chinese medicine formula (kunbixiao granule) for female rheumatoid arthritis: Study protocol for a double-blind, randomized, placebo-controlled trial
por: Wan, Yingying, et al.
Publicado: (2022)

Efficacy and Mechanism of Buyang Huanwu Decoction in Patients With Ischemic Heart Failure: A Randomized, Double-Blind, Placebo-Controlled Trial Combined With Proteomic Analysis
por: Zhu, Mingjun, et al.
Publicado: (2022)

Qishen granules inhibit myocardial inflammation injury through regulating arachidonic acid metabolism
por: Li, Chun, et al.
Publicado: (2016)

Protective effect of Qishen Yiqi dropping pills on the myocardium of rats with chronic heart failure
por: Lu, Yinghong, et al.
Publicado: (2019)

Hengli(®) Chinese Botulinum Toxin Type A for Treatment of Patients With Overactive Bladder: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
por: Liao, Limin, et al.
Publicado: (2022)

Qishen Yiqi dripping pills for ischemic heart failure: A protocol for a prospective cohort study
por: Zhao, Zhiqiang, et al.
Publicado: (2018)

Quanduzhong capsules for the treatment of grade 1 hypertension patients with low-to-moderate risk: A multicenter, randomized, double-blind, placebo-controlled clinical trial
por: Xu, Xuan, et al.
Publicado: (2023)

Safety, tolerability and pharmacokinetics of WXFL10203614 in healthy Chinese subjects: A randomized, double-blind, placebo-controlled phase Ⅰ study
por: Huang, Kai, et al.
Publicado: (2022)

Efficacy and Safety of Ganduqing Granules in Treating the Common Cold: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Wang, Yilan, et al.
Publicado: (2022)

Efficacy and safety of naotaifang capsules for hypertensive cerebral small vessel disease: Study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial
por: Fang, Rui, et al.
Publicado: (2023)

Efficacy of Qishen Yiqi Drop Pill for Chronic Heart Failure: An Updated Meta-Analysis of 85 Studies
por: Wang, Hao, et al.
Publicado: (2020)

Efficacy and safety of Qiangli Dingxuan tablet combined with amlodipine besylate for essential hypertension: a randomized, double-blind, placebo-controlled, parallel-group, multicenter trial
por: Lin, Jianguo, et al.
Publicado: (2023)

Efficacy of Mudan Granule (Combined With Methylcobalamin) on Type 2 Diabetic Peripheral Neuropathy: Study Protocol for a Double-Blind, Randomized, Placebo-Controlled, Parallel-Arm, Multi-Center Trial
por: Zhang, Yuehong, et al.
Publicado: (2021)

The role of Qishen Yiqi dripping pills in treating chronic heart failure: An overview of systematic reviews and meta-analyses
por: Chen, Wensheng, et al.
Publicado: (2022)

Efficacy and safety of a Chinese herbal formula Maxing Ganshi Decoction in children with community-acquired pneumonia: A randomized, double-blind, placebo-controlled, multicenter trial
por: Zheng, Yujiao, et al.
Publicado: (2022)

Efficacy and Safety of Wenbu Zhibi Granule in Patients with Ankylosing Spondylitis: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial
por: Zhang, Helou, et al.
Publicado: (2021)

Qishen Yiqi dripping pills for chronic ischaemic heart failure: results of the CACT‐IHF randomized clinical trial
por: Mao, Jingyuan, et al.
Publicado: (2020)

Efficacy of jianpi huatan granule in reducing colorectal cancer metastasis and recurrence after radical resection and adjuvant chemotherapy: Study protocol for a randomised, double-blind, placebo-controlled, multicentre trial
por: Li, Liusheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_65ljr6iapl8jvpjlf7soi1b6he